Nexalin Technology, Inc. (NXL)
NASDAQ: NXL · Real-Time Price · USD
2.630
-0.430 (-14.05%)
At close: Dec 20, 2024, 4:00 PM
2.750
+0.120 (4.56%)
After-hours: Dec 20, 2024, 6:41 PM EST
Nexalin Technology Employees
Nexalin Technology had 6 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
6
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$27,013
Profits / Employee
-$925,763
Market Cap
33.83M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 6 | 0 | - |
Dec 31, 2022 | 6 | -4 | -40.00% |
Dec 31, 2021 | 10 | 6 | 150.00% |
Dec 31, 2020 | 4 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Achilles Therapeutics | 215 |
Neuronetics | 203 |
CASI Pharmaceuticals | 176 |
Passage Bio | 58 |
AN2 Therapeutics | 41 |
SCYNEXIS | 29 |
Aileron Therapeutics | 15 |
Lexaria Bioscience | 7 |
NXL News
- 25 days ago - New Peer-Reviewed Publication Validates Nexalin's Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market - GlobeNewsWire
- 7 weeks ago - Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on November 5th - GlobeNewsWire
- 7 weeks ago - Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements - GlobeNewsWire
- 7 weeks ago - LOBO EV and Nexalin Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 7 weeks ago - Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease - GlobeNewsWire
- 2 months ago - Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 2 months ago - Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA - GlobeNewsWire
- 2 months ago - New Study Shows Nexalin's Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer's Patients - GlobeNewsWire